A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Investigational Site Number : 214, Sofia

Investigational Site Number : 541, Grålum

Investigational Site Number : 104, Sydney

Investigational Site Number : 105, Canberra

Investigational Site Number : 106, Parkville

Investigational Site Number : 101, Clayton

Investigational Site Number : 102, Woolloongabba

Investigational Site Number : 213, Pleven

Investigational Site Number : 103, Perth

Investigational Site Number : 211, Varna

New York Presbyterian Hospital/Weill Cornell Medical Center Site Number : 1097, New York

Investigational Site Number : 432, Prague

Pitt County Memorial Hospital Site Number : 1095, Greenville

Mid Michigan Medical Center Site Number : 1086, Midland

Investigational Site Number : 433, Hradec Králové

Bleeding and Clotting Disorders Institute Site Number : 1087, Peoria

Investigational Site Number : 431, Brno

Investigational Site Number : 434, Ostrava - Poruba

RCCA MC LLC Site Number : 1091, Bethesda

Massachusetts General Hospital Cancer Center Site Number : 1092, Boston

Beth Israel Deaconess Medical Center Site Number : 1099, Boston

Seattle Cancer Care Alliance Site Number : 1098, Seattle

Investigational Site Number : 1161, Toronto

Investigational Site Number : 1162, Montreal

Investigational Site Number : 727, Rotterdam

Investigational Site Number : 728, The Hague

Investigational Site Number : 542, Bergen

Investigational Site Number : 981, Leicester

Investigational Site Number : 983, London

Investigational Site Number : 980, London

Investigational Site Number : 984, Birmingham